Trials / Completed
CompletedNCT05448001
Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
A Multi-center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 329 (actual)
- Sponsor
- Onconic Therapeutics Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients with Gastric Ulcer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JP-1366 20mg | JP-1366 20 mg 1 capsule, Lansoprazole 30 mg placebo 1 capsule before meal |
| DRUG | Lansoprazole 30mg | JP-1366 20 mg placebo 1 capsule, Lansoprazole 30 mg 1 capsule before meal |
Timeline
- Start date
- 2022-09-19
- Primary completion
- 2024-07-10
- Completion
- 2024-07-19
- First posted
- 2022-07-07
- Last updated
- 2024-08-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05448001. Inclusion in this directory is not an endorsement.